Efficacy and safety of ultrasound-guided percutaneous polidocanol sclerotherapy in benign predominantly cystic thyroid nodules: a prospective study

References

• McHenry CR, Slusarczyk SJ, Khiyami A. Recommendations for management of cystic thyroid disease. Surgery 1999;126:1167-72
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-65
   PubMed Web of Science ®Google Scholar
• Bennedbæk FN, Hegedüs L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003;88:5773-7
   PubMed Web of Science ®Google Scholar
• Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Prac 2010;16(Suppl1):1-43
   Web of Science ®Google Scholar
• Kim YJ, Baek JH, Ha EJ, et al. Cystic versus predominantly cystic thyroid nodules: Efficacy of ethanol ablation and analysis of related factors. Eur Radiol 2012;22:1573-8
   PubMed Web of Science ®Google Scholar
• Jang SW, Baek JH, Kim JK, et al. How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: Role of radiofrequency ablation. Eur J Radiol 2012;81:905-10
   PubMed Web of Science ®Google Scholar
• Suh CH, Baek JH, Ha EJ, et al. Ethanol ablation of predominantly cystic thyroid nodules: Evaluation of recurrence rate and factors related to recurrence. Clin Radiol 2015;70:42-7
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim YS, Lee D, et al. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). W J Surg 2010;34:1488-93
   PubMed Web of Science ®Google Scholar
• Grover C, Khurana A, Bhattacharya SN. Sclerotherapy for the treatment of infantile hemangiomas. J Cutan Aesth Surg 2012;5:201-3
   PubMedGoogle Scholar
• Rabe E, Pannier F. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the german society of phlebology: Original articles. Derm Surg 2010;36(Suppl2):968-75
   Web of Science ®Google Scholar
• Klode J, Klötgen K, Körber A, et al. Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele. J Eur Acad Dermatol Venereol 2010;24:904-9
   PubMed Web of Science ®Google Scholar
• Brunken C, Pfeiffer D, Tauber R. [Long term outcome after percutaneous sclerotherapy of renal cysts with polidocanol]. Der Urologe Ausg A 2002;41:263-6
   PubMedGoogle Scholar
• Jahnson S, Sandblom D, Holmng S. A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatocele. J Urol 2011;186:1319-23
   PubMed Web of Science ®Google Scholar
• Spârchez Z, Radu P, Zaharie F, et al. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol. Med Ultrasonograph 2014;16:222-8
   PubMed Web of Science ®Google Scholar
• Sung JY, Kim YS, Choi H, et al. Optimum first-line treatment technique for benign cystic thyroid nodules: Ethanol ablation or radiofrequency ablation? Am J Roentgenol 2011;196:210-14
   PubMed Web of Science ®Google Scholar
• Sacks LCD, McClenny TE, Cardella JF. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14:199-202
   PubMed Web of Science ®Google Scholar
• Yoon HM, Baek JH, Lee JH, et al. Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. Am J Neuroradiol 2014;35:582-6
   PubMed Web of Science ®Google Scholar
• Moon WJ, Baek JH, Jung SL, et al. Ultrasonography and the ultrasound-based management of thyroid nodules: Consensus statement and recommendations. Kor J Radiol 2011;12:1-14
   PubMed Web of Science ®Google Scholar
• Zingrillo M, Torlontano M, Chiarella R, et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid Offic J Am Thyroid Assoc 1999;9:763-7
   PubMed Web of Science ®Google Scholar
• Del Prete S, Caraglia M, Russo D, et al. Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid 2002;12:815-21
   PubMed Web of Science ®Google Scholar
• Commentary I. Role of percutaneous ethanol injection in management of nodular lesions of the thyroid gland. 1990;211-13
   Google Scholar
• Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: Safety and imaging follow-up in 236 patients. Eur Radiol 2008;18:1244-50
   PubMed Web of Science ®Google Scholar
• Yonguc T, Sen V, Aydogdu O, et al. The comparison of percutaneous ethanol and polidocanol sclerotherapy in the management of simple renal cysts. Int Urol Nephrol 2015;47:603-7
   PubMed Web of Science ®Google Scholar
• Esson GA, Holme SA. Treatment of 63 subjects with digital mucous cysts with percutaneous sclerotherapy using polidocanol. 2016;59-62
   Google Scholar
• Jie X, Geng X. Curative effect of lauromacrogol and absolute ethyl alcohol injection guided by ultrasound on simplex hepatic cyst. 2014;153:697-700
   Google Scholar
• Dell’Atti L. Comparison between the use of 99% ethanol and 3% polidocanol in percutaneous echoguided sclerotherapy treatment of simple renal cysts. Urol Ann 2015
   Web of Science ®Google Scholar
• Belcaro IEG, Corsi M, Ricci A, et al. Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. Panminerva Med 2012;54:73-6
   PubMed Web of Science ®Google Scholar
• Zhijiang C, Long W, Yijing H, et al. Efficacy of ultrasound-guided lauromacrogol sclerotherapy for benign thyroid cysts and factors affecting the therapeutic effect. 2016;36:1694-9
   Google Scholar
• Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg Offic Publ Am Soc Dermatol Surg 2005;31:636-43
   PubMed Web of Science ®Google Scholar
• Ufuk Oguz Idiz H, Erhan Aysan, Ismail Can, et al. The effects of lauromacrogol on thyroid tissue in rabbits. Is this a safe option for the treatment of nodular thyroid disease? Ann Ital Chir 2016;87:192-7
   PubMed Web of Science ®Google Scholar
• Kalra N, Ahuja CK, Dutta P, et al. Comparison of sonographically guided percutaneous sodium tetradecyl sulfate injection with ethanol injection in the treatment of benign nonfunctioning thyroid nodules. J Vasc Intervent Radiol 2014;25:1218-24
   PubMed Web of Science ®Google Scholar
• In HS, Kim DW, Choo HJ, et al. Ethanol ablation of benign thyroid cysts and predominantly cystic thyroid nodules: Factors that predict outcome. Endocrine 2014;46:107-13
   PubMed Web of Science ®Google Scholar
• Baek JH, Ha EJ, Choi YJ, et al. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial. 2015;16:1332-40
   Google Scholar